Quantbot Technologies LP Passage Bio, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$1.22 - $2.48 $122 - $248	-100 Reduced 2.63%	3,700 $4,000
Q2 2022 Aug 09, 2022	SELL	$1.63 - $3.46 $4,074 - $8,650	-2,500 Reduced 39.68%	3,800 $8,000
Q1 2022 May 16, 2022	SELL	$2.66 - $6.49 $532 - $1,298	-200 Reduced 3.08%	6,300 $19,000
Q4 2021 Feb 11, 2022	BUY	$6.24 - $10.2 $4,368 - $7,139	700 Added 12.07%	6,500 $41,000
Q3 2021 Nov 09, 2021	BUY	$9.73 - $15.52 $46,704 - $74,496	4,800 Added 480.0%	5,800 $57,000
Q2 2021 Aug 12, 2021	BUY	$12.44 - $19.45 $12,440 - $19,450	1,000 New	1,000 $13,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $32.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.